170 related articles for article (PubMed ID: 14503864)
1. Unexpected binding mode for 2'-phosphoadenosine-based nucleotide inhibitors in complex with human angiogenin revealed by heteronuclear NMR spectroscopy.
Tonan K; Xu P; Jenkins JL; Russo A; Shapiro R; Ni F
Biochemistry; 2003 Sep; 42(38):11137-49. PubMed ID: 14503864
[TBL] [Abstract][Full Text] [Related]
2. Toward rational design of ribonuclease inhibitors: high-resolution crystal structure of a ribonuclease A complex with a potent 3',5'-pyrophosphate-linked dinucleotide inhibitor.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1999 Aug; 38(32):10287-97. PubMed ID: 10441122
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the interactions of human ribonuclease inhibitor with angiogenin and ribonuclease A by mutagenesis: importance of inhibitor residues inside versus outside the C-terminal "hot spot".
Shapiro R; Ruiz-Gutierrez M; Chen CZ
J Mol Biol; 2000 Sep; 302(2):497-519. PubMed ID: 10970748
[TBL] [Abstract][Full Text] [Related]
4. Binding of phosphate and pyrophosphate ions at the active site of human angiogenin as revealed by X-ray crystallography.
Leonidas DD; Chavali GB; Jardine AM; Li S; Shapiro R; Acharya KR
Protein Sci; 2001 Aug; 10(8):1669-76. PubMed ID: 11468363
[TBL] [Abstract][Full Text] [Related]
5. Crystal structures of ribonuclease A complexes with 5'-diphosphoadenosine 3'-phosphate and 5'-diphosphoadenosine 2'-phosphate at 1.7 A resolution.
Leonidas DD; Shapiro R; Irons LI; Russo N; Acharya KR
Biochemistry; 1997 May; 36(18):5578-88. PubMed ID: 9154942
[TBL] [Abstract][Full Text] [Related]
6. Identification of small-molecule inhibitors of human angiogenin and characterization of their binding interactions guided by computational docking.
Jenkins JL; Shapiro R
Biochemistry; 2003 Jun; 42(22):6674-87. PubMed ID: 12779322
[TBL] [Abstract][Full Text] [Related]
7. Temperature dependence of the backbone dynamics of ribonuclease A in the ground state and bound to the inhibitor 5'-phosphothymidine (3'-5')pyrophosphate adenosine 3'-phosphate.
Kovrigin EL; Cole R; Loria JP
Biochemistry; 2003 May; 42(18):5279-91. PubMed ID: 12731869
[TBL] [Abstract][Full Text] [Related]
8. High-resolution crystal structures of ribonuclease A complexed with adenylic and uridylic nucleotide inhibitors. Implications for structure-based design of ribonucleolytic inhibitors.
Leonidas DD; Chavali GB; Oikonomakos NG; Chrysina ED; Kosmopoulou MN; Vlassi M; Frankling C; Acharya KR
Protein Sci; 2003 Nov; 12(11):2559-74. PubMed ID: 14573867
[TBL] [Abstract][Full Text] [Related]
9. Superadditive and subadditive effects of "hot spot" mutations within the interfaces of placental ribonuclease inhibitor with angiogenin and ribonuclease A.
Chen CZ; Shapiro R
Biochemistry; 1999 Jul; 38(29):9273-85. PubMed ID: 10413501
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of 3',5'-pyrophosphate-linked dinucleotides by ribonuclease A and angiogenin.
Jardine AM; Leonidas DD; Jenkins JL; Park C; Raines RT; Acharya KR; Shapiro R
Biochemistry; 2001 Aug; 40(34):10262-72. PubMed ID: 11513604
[TBL] [Abstract][Full Text] [Related]
11. 5'-Modified pyrimidine nucleosides as inhibitors of ribonuclease A.
Samanta A; Dasgupta S; Pathak T
Bioorg Med Chem; 2011 Apr; 19(7):2478-84. PubMed ID: 21420869
[TBL] [Abstract][Full Text] [Related]
12. 5'-Diphosphoadenosine 3'-phosphate is a potent inhibitor of bovine pancreatic ribonuclease A.
Russo N; Shapiro R; Vallee BL
Biochem Biophys Res Commun; 1997 Feb; 231(3):671-4. PubMed ID: 9070868
[TBL] [Abstract][Full Text] [Related]
13. A combined kinetic and modeling study of the catalytic center subsites of human angiogenin.
Russo N; Acharya KR; Vallee BL; Shapiro R
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):804-8. PubMed ID: 8570639
[TBL] [Abstract][Full Text] [Related]
14. Using proton nuclear magnetic resonance to study the mode of ribonuclease A inhibition by competitive and noncompetitive inhibitors.
Ghosh KS; Debnath J; Pathak T; Dasgupta S
Bioorg Med Chem Lett; 2008 Oct; 18(20):5503-6. PubMed ID: 18812256
[TBL] [Abstract][Full Text] [Related]
15. Site-specific mutagenesis reveals differences in the structural bases for tight binding of RNase inhibitor to angiogenin and RNase A.
Chen CZ; Shapiro R
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1761-6. PubMed ID: 9050852
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of mammalian ribonucleases by endogenous adenosine dinucleotides.
Kumar K; Jenkins JL; Jardine AM; Shapiro R
Biochem Biophys Res Commun; 2003 Jan; 300(1):81-6. PubMed ID: 12480524
[TBL] [Abstract][Full Text] [Related]
17. Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution.
Papageorgiou AC; Shapiro R; Acharya KR
EMBO J; 1997 Sep; 16(17):5162-77. PubMed ID: 9311977
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of ribonuclease inhibition by ribonuclease inhibitor protein based on the crystal structure of its complex with ribonuclease A.
Kobe B; Deisenhofer J
J Mol Biol; 1996 Dec; 264(5):1028-43. PubMed ID: 9000628
[TBL] [Abstract][Full Text] [Related]
19. Selective abolition of pancreatic RNase binding to its inhibitor protein.
Kumar K; Brady M; Shapiro R
Proc Natl Acad Sci U S A; 2004 Jan; 101(1):53-8. PubMed ID: 14681553
[TBL] [Abstract][Full Text] [Related]
20. The binding of IMP to ribonuclease A.
Hatzopoulos GN; Leonidas DD; Kardakaris R; Kobe J; Oikonomakos NG
FEBS J; 2005 Aug; 272(15):3988-4001. PubMed ID: 16045769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
